[go: up one dir, main page]

PE20110327A1 - Vacuna contra el virus de papiloma humano - Google Patents

Vacuna contra el virus de papiloma humano

Info

Publication number
PE20110327A1
PE20110327A1 PE2011000104A PE2011000104A PE20110327A1 PE 20110327 A1 PE20110327 A1 PE 20110327A1 PE 2011000104 A PE2011000104 A PE 2011000104A PE 2011000104 A PE2011000104 A PE 2011000104A PE 20110327 A1 PE20110327 A1 PE 20110327A1
Authority
PE
Peru
Prior art keywords
human papilloma
papilloma virus
against human
vaccine against
vaccine
Prior art date
Application number
PE2011000104A
Other languages
English (en)
Inventor
Dominique Descamps
Sandra Giannini
Nicolas Lecrenier
Jean Stephenne
Martine Anne Cecile Wettendorff
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of PE20110327A1 publication Critical patent/PE20110327A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UNA VACUNA QUE COMPRENDE: A) PARTICULAS SIMILARES A VIRUS (VLPs) DEL VIRUS DE PAPILOMA HUMANO HPV 16 Y HPV 18 EN UNA CANTIDAD DE 20ug O 40ug CADA UNO; Y B) UN ADYUVANTE TAL COMO HIDROXIDO DE ALUMINIO Y EL LIPIDO A DE 3-O-DESACIL-4'-MONOFOSFORILO (3D-MPL). DONDE DICHA VACUNA SE ADMINISTRA EN DOS DOSIS SIENDO UTIL EN EL TRATAMIENTO DE LA INFECCION PRODUCIDA POR EL VIRUS DE PAPILOMA HUMANO EN MUJERES CON EDADES DE 25 ANOS O MENOS
PE2011000104A 2008-07-31 2009-07-29 Vacuna contra el virus de papiloma humano PE20110327A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US17656109P 2009-05-08 2009-05-08

Publications (1)

Publication Number Publication Date
PE20110327A1 true PE20110327A1 (es) 2011-06-29

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011000104A PE20110327A1 (es) 2008-07-31 2009-07-29 Vacuna contra el virus de papiloma humano

Country Status (26)

Country Link
US (1) US20110189229A1 (es)
EP (1) EP2318042B1 (es)
JP (1) JP6022159B2 (es)
KR (1) KR20110053340A (es)
CN (1) CN102159239A (es)
AU (1) AU2009275909A1 (es)
BR (1) BRPI0916732B1 (es)
CA (1) CA2732436C (es)
CO (1) CO6341567A2 (es)
DK (1) DK2318042T3 (es)
DO (1) DOP2011000031A (es)
EA (1) EA201170264A1 (es)
ES (1) ES2519490T3 (es)
HR (1) HRP20141063T1 (es)
IL (1) IL210977A0 (es)
MA (1) MA32554B1 (es)
MX (1) MX2011001218A (es)
NZ (1) NZ590919A (es)
PE (1) PE20110327A1 (es)
PL (1) PL2318042T3 (es)
PT (1) PT2318042E (es)
RS (1) RS53607B1 (es)
SI (1) SI2318042T1 (es)
SM (1) SMT201400170B (es)
WO (1) WO2010012780A1 (es)
ZA (1) ZA201100889B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010264695A1 (en) 2009-06-25 2012-01-19 Glaxosmithkline Biologicals S.A. Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) * 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
EP3191505A2 (en) * 2014-09-11 2017-07-19 Cadila Healthcare Limited Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
US10063211B2 (en) 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ
US20210302427A1 (en) * 2020-03-31 2021-09-30 Shuhari Group, LLC Secure Immunity Information Transmission System And Network
WO2025147639A1 (en) * 2024-01-04 2025-07-10 Cyanvac Llc Improved formulation providing increased stability for vaccines composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1732598A4 (en) * 2003-12-31 2009-08-26 Pharmexa Inc TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
PL1758609T3 (pl) * 2004-06-16 2013-02-28 Glaxosmithkline Biologicals Sa Szczepionka przeciw HPV16 i HPV18 oraz co najmniej jednemu HPV innego typu wybranemu spośród HPV 31, 45 lub 52
EA013326B1 (ru) * 2005-04-26 2010-04-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина

Also Published As

Publication number Publication date
ES2519490T3 (es) 2014-11-07
HRP20141063T1 (hr) 2015-01-02
RS53607B1 (sr) 2015-04-30
EA201170264A1 (ru) 2011-08-30
BRPI0916732A2 (pt) 2017-01-31
PT2318042E (pt) 2014-11-05
KR20110053340A (ko) 2011-05-20
EP2318042B1 (en) 2014-08-20
CO6341567A2 (es) 2011-11-21
CA2732436A1 (en) 2010-02-04
CN102159239A (zh) 2011-08-17
SI2318042T1 (sl) 2014-12-31
PL2318042T3 (pl) 2015-02-27
IL210977A0 (en) 2011-04-28
BRPI0916732B1 (pt) 2021-06-29
US20110189229A1 (en) 2011-08-04
AU2009275909A1 (en) 2010-02-04
JP2011529475A (ja) 2011-12-08
NZ590919A (en) 2012-10-26
MA32554B1 (fr) 2011-08-01
JP6022159B2 (ja) 2016-11-09
DK2318042T3 (da) 2014-11-10
SMT201400170B (it) 2015-01-15
ZA201100889B (en) 2012-04-25
CA2732436C (en) 2018-01-16
MX2011001218A (es) 2011-03-15
WO2010012780A1 (en) 2010-02-04
EP2318042A1 (en) 2011-05-11
DOP2011000031A (es) 2011-02-28

Similar Documents

Publication Publication Date Title
PE20110327A1 (es) Vacuna contra el virus de papiloma humano
UA114351C2 (uk) Поліциклічні карбамоїлпіридонові сполуки та їх фармацевтичне застосування
CO6491048A2 (es) Inhibidores de la replicación de los virus de la gripe
FI20115738A0 (fi) Apuväline suun ja hampaiden hoidon yhteydessä
EA201390332A1 (ru) Дейтерированные аналоги придопидина, применимые в качестве допаминергических стабилизаторов
EA200970013A1 (ru) Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы
JP2009173664A5 (es)
NZ587798A (en) Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer
AR083361A1 (es) Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
CL2011001993A1 (es) Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio; metodo de produccion; y su uso para prevenir, mejorar o tratar una enfermedad productiva por el virus del dengue en un sujeto.
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
BR112015014243A2 (pt) composição de vacina para uso em populações imunocomprometidas
CO2022011392A2 (es) Vacuna contra hpv
PE20230349A1 (es) Vacunas para la papilomatosis respiratoria recurrente y metodos para usar estas
EA201690057A1 (ru) Остеопонтин молока млекопитающих для повышения иммунологической реактивности
MX2013003245A (es) Vacuna contra virus de diarrea viral de bovinos.
BR112016025977A2 (pt) composições, métodos e utilizações para formulações de papilomavirus humano estábulo estável
EA201290319A1 (ru) Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)
NZ580603A (en) Intradermal influenza vaccine
CN202459501U (zh) 吸痰病原菌散播控制器
NZ567095A (en) Anti-infective agent and use thereof
MX2021016040A (es) Composicion farmaceutica para el tratamiento de infecciones de virus de influenza.
PE20061320A1 (es) Vacuna contra virus de papiloma humano (hpv)
CY1115704T1 (el) Εμβολιο κατα του hpv

Legal Events

Date Code Title Description
FC Refusal